Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125944361 | 12594436 | 1 | I | 20160602 | 20160726 | 20160726 | PER | US-ASTRAZENECA-2016SE60727 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125944361 | 12594436 | 1 | PS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | U | 20639 | TABLET | |||||||||
| 125944361 | 12594436 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Intramuscular | U | 0 | 400 | MG | QD | |||||||
| 125944361 | 12594436 | 3 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 125944361 | 12594436 | 4 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | U | 0 | ||||||||||
| 125944361 | 12594436 | 5 | SS | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125944361 | 12594436 | Condition aggravated | |
| 125944361 | 12594436 | Delusion | |
| 125944361 | 12594436 | Hallucination, auditory | |
| 125944361 | 12594436 | Insomnia | |
| 125944361 | 12594436 | Paranoia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |